Search

everythinglearnresearchcommunity

for

Search:↓

The conclusion is that a treatment called cp-asiAR can reduce hair loss and promote hair growth, making it a potential new therapy for androgenetic alopecia.

R-spondins and their receptors help increase bone growth and may be used to treat bone loss diseases.

LX-38 is a safer drug option for treating prostate issues and hair loss without hormonal side effects.

The document concludes that ERBB2 mutations are common in extramammary Paget disease and may respond to systemic treatments like cancer immunotherapy.

Ribonucleotide excision repair is crucial to prevent skin cancer.

A new genetic mutation in the ODC1 gene causes developmental delay and other symptoms in a young girl.

The near-naked hairless mutation causes hair loss but is not due to a mutation in the hairless gene itself.

New lipid/fiber microplexes improve mRNA therapy for degenerative diseases by enhancing cell function and treatment effectiveness.

Two microRNAs affect hair follicle development in sheep by targeting specific genes.

Scientists successfully created and analyzed the structure of a part of the human androgen receptor with specific modulators and a peptide to understand how it binds differently in various tissues.

ARL15 is important for fat cell development and the release of the hormone adiponectin.

Exosomal miR-222-3p reduces melanin production in rabbits by targeting the SOX10 gene.

A substance called miR-1246 may help treat severe hair loss by reducing certain immune cell activities.

Noncoding dsRNA boosts hair growth by activating TLR3 and increasing retinoic acid.

The tumor suppressor gene FLCN affects mitochondrial function and energy use in cells.

Haplogroup X found in Altaian population supports Amerindian origin.

ASLAN004 was safe and well-tolerated, supporting further development for treating certain diseases.

A new gene mutation causes vitamin D-resistant rickets and hair loss in two siblings.

RORA plays a key role in controlling seasonal hair molting by affecting hair follicle cell activity.

KRT80 may worsen cancer by increasing growth and spread, but its full effects on treatment and outcomes need more research.

The treatment showed high response rates and was well-tolerated, potentially extending patient survival.

PRMT5 inhibitors effectively fight adenoid cystic carcinoma in salivary glands.

GKLF/KLF4 and Sp1 control Keratin 19 gene activity, influencing cancer-related changes.

Early and accurate diagnosis is crucial for managing rare genetic disorders like this localized variant of junctional epidermolysis bullosa.

The antibody 005-C04 blocks prolactin receptors, causing reversible infertility, impaired lactation, and hair regrowth in female mice.

LGR5 is a common marker of hair follicle stem cells in different animals and is important for hair growth and regeneration.

Eribulin-based chemotherapy is more effective and has fewer side effects for advanced triple-negative breast cancer.

Researchers found a new mutation causing total hair loss from birth.

Alopecia areata involves both innate and adaptive immunity, with specific genes linked to the disease.

Double-stranded RNA causes inflammation in hair follicle cells, which may help understand and treat alopecia areata.